MALIGNANT GENITOURINARY TRACT NEOPLASM

MALIGNANT GENITOURINARY TRACT NEOPLASM was reported 67 times

These drug classes are most commonly taken by patients reporting MALIGNANT GENITOURINARY TRACT NEOPLASM:

# Drug Count
0 Alkylating Drug [EPC] 27
1 CD19-directed Chimeric Antigen Receptor [EPC] 24
2 Genetically-modified Autologous T Cells [EPC] 24
3 CD20-directed Cytolytic Antibody [EPC] 5
4 Corticosteroid [EPC] 4
5 Platinum-based Drug [EPC] 4
6 Topoisomerase Inhibitor [EPC] 3
7 Tumor Necrosis Factor Blocker [EPC] 3
8 Nucleoside Metabolic Inhibitor [EPC] 2
9 Programmed Death Ligand-1 Blocker [EPC] 2
10 Programmed Death Receptor-1 Blocking Antibody [EPC] 2
11 Proteasome Inhibitor [EPC] 2
12 Provitamin D2 Compound [EPC] 2
13 Thalidomide Analog [EPC] 2
14 Androgen Receptor Inhibitor [EPC] 1
15 Angiotensin 2 Receptor Blocker [EPC] 1
16 BCL-2 Inhibitor [EPC] 1
17 Benzodiazepine [EPC] 1
18 CTLA-4-directed Blocking Antibody [EPC] 1
19 Calcium Channel Blocker [EPC] 1
20 Calcium [EPC] 1
21 Dihydropyridine Calcium Channel Blocker [EPC] 1
22 Epidermal Growth Factor Receptor Antagonist [EPC] 1
23 Expectorant [EPC] 1
24 Factor Xa Inhibitor [EPC] 1
25 HMG-CoA Reductase Inhibitor [EPC] 1
26 Insulin Analog [EPC] 1
27 Integrin Receptor Antagonist [EPC] 1
28 Interleukin-12 Antagonist [EPC] 1
29 Interleukin-23 Antagonist [EPC] 1
30 Interleukin-4 Receptor alpha Antagonist [EPC] 1
31 Kinase Inhibitor [EPC] 1
32 Melatonin Receptor Agonist [EPC] 1
33 Microtubule Inhibitor [EPC] 1
34 Nonergot Dopamine Agonist [EPC] 1
35 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
36 Phosphodiesterase 4 Inhibitor [EPC] 1
37 Radioligand Therapeutic Agent [EPC] 1
38 Serotonin-3 Receptor Antagonist [EPC] 1
39 Thiazide-like Diuretic [EPC] 1
40 Vitamin C [EPC] 1